Inhibition of thrombin-induced contractile responses by protein kinase inhibitors in porcine pulmonary arteries

Experimental and Toxicologic Pathology

Volumn 50, Issue 4-6, 1998, Pages 497-500

  Kutz, Christoph ^a   Paintz, Manfred ^a   Glusa, Erika ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Contraction, blood vessels, thrombin; Phorbol ester; Protein kinase inhibitors; Pulmonary arteries; Thrombin, contraction, blood vessels; Tyrosine kinase inhibitors

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; BISINDOLYLMALEIMIDE; CHELERYTHRINE; GENISTEIN; PHORBOL DIBUTYRATE; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; STAUROSPORINE; THROMBIN;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL REACTIVITY; ENZYME ACTIVATION; NONHUMAN; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SWINE; VASCULAR ENDOTHELIUM;

EID: 0031708573     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(98)80040-7     Document Type: Article

References (20)

1. ABEBE W , AGRAWAL DK Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol 1995; 26: 153-159.
2. ABEBE W, MACLEOD KM Proteinkinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol 1990; 101: 465-471.
3. BRETSCHNEIDER E, PAINTZ M, GLUSA E Inositol 1,4,5-triphosphate and protein kinase C are involved in thrombinand TRAP- induced vascular smooth muscle contraction. Agents Actions 1995; 45: 309-313.
4. DERIAN CK, SANTULLI RJ, TOMKO KA, et'al.: Species differences in platelet responses to thrombin and SFLLRN, Receptor-mediated calcium mobilization and aggre-gation, and regulation by protein kinases. Thromb Res. 1995;78:505-519.
5. FILIPEANU CM, BRAILOIU E, HUHUREZ G, et al. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction. Eur J Pharmacol 1995; 281: 29-35.
6. GLUSA E Vascular effects of thrombin. Semin Thromb Hemost 1992; 18: 296-304.
7. GLUSA E, BRETSCHNEIDER E, PAINTZ M Contractile effects of thrombin in porcine pulmonary arteries and the influence of thrombin inhibitors. Naunyn Schmiedeberg's Arch Pharmacol 1994; 349: 101-106.
8. GODIN D, Rioux F, MARCEAU F, DRAPEAU G Mode of action of thrombin in the rabbit aorta. Br J Pharmacol 1995; 115: 903-908.
9. GRAND RJA, TURNELL AS, GRABHAM PW Cellular consequences of thrombin receptor activation. Biochem J 1996;313:353-368.
10. MCNICOL A, GERRARD JM Post-receptor events associated with thrombin-induced platelet activation. Blood Coagul Fibrinolysis 1993; 4: 975-991.
11. 2+channels and phospholipase C. J Pharmacol Exp Therap 1985; 234: 442-446.
12. NEGRESCU EV, LUBER DE QUINTANA K, SIESS W Platelet shape change induced by thrombin receptor activation. J Biol Chem 1995; 270: 1057-1061.
13. RASMUSSEN H, TAKUWA Y, PARK S Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1987; 1: 177-186.
14. 2+ mobilization. FEBS Lett 1991; 228: 123-128.
15. RENDU F, ELDOR A, GRELAC F, et al. Inhibition of platelet activation by tyrosine kinase inhibitors. Biochem Pharmacol 1992; 44: 881-888.
16. RÜEGG UT, BURGES GM Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sei 1989; 10: 218-220.
17. TESFAMARIAM B Distinct receptors and signaling pathways in α-thrombin- and thrombin receptor peptide-induced vascular contractions. Circ Res 1994; 74:930-936.
18. VAN OBBERGHEN-SCHILLING E, POUYSSEGUR J Signalling pathways of the thrombin receptor. Thromb Haemost 1993;70: 163-167.
19. VU TKH, HUNG DT, WHEATON VI, COUGHLIN SR Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068.
20. WATTS SW, YEUM CH, CAMPBELL G, WEBB RC Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J Vase Res 1996; 33: 288-298.